These observations warrant further investigation in pre-clinical animal models and may also have relevance for other tumor types where MYC or MYCN amplification is observed, such as breast cancer, small-cell lung cancer, retinoblastoma, medulloblastoma, rhabdomyosarcoma, and astrocytoma. The gene discussed is MYCN; the disease is astrocytoma (excluding glioblastoma).